Anne-Charlotte Le Floch

Dr. Anne-Charlotte Le Floch

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
CICaroline Imbert
Caroline Imbert
NBNicolas Boucherit
Nicolas Boucherit
Laurent GorvelLaurent Gorvel
Laurent Gorvel
SFStéphane Fattori
Stéphane Fattori
DODaniel Olive
Daniel Olive
Vγ9Vδ2 T cells are potent but elusive cytotoxic effectors. Butyrophilin subfamily 2 member A1 (BTN2A1) is a surface protein that has recently been shown to bind the Vγ9 chain of the γδ T-cell receptor, but its precise role in modulating Vγ9Vδ2 T-cell functions remains unknown. Here, we show that 107G3B5, a monoclonal BTN2A1 agonist antibody, was able to significantly enhance Vγ9Vδ2 T-cell functions against hematologic or solid cell lines and against primary cells from patients with adult acute lymphoblastic leukemia. New computer vision strategies applied to holotomographic microscopy videos showed that 107G3B5 enhanced the interaction between Vγ9Vδ2 T cells and target cells in a quantitative and qualitative manner. In addition, we found that Vγ9Vδ2 T cells activated by 107G3B5 induced caspase 3/7 activation in tumor cells, thereby triggering tumor cell death by pyroptosis. Together, these data demonstrate that targeting BTN2A1 with 107G3B5 enhances the Vγ9Vδ2 T-cell antitumor response by triggering pyroptosis-induced immunogenic cell death. These new pyroptosis-based therapies have great potential to stimulate the immune system to fight cancer, especially “cold” tumors. See related Spotlight by Kabelit, p. 1662

14 August 2024 in Blood Advances
Verified
Journal Article
Open access
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
FOFlorence Orlanducci
Florence Orlanducci
Marie BénéMarie Béné
Marie Béné
AAAmira Ben Amara
Amira Ben Amara
MRMarie-Sarah Rouviere
Marie-Sarah Rouviere
DODaniel Olive
Daniel Olive
In several tumor subtypes, an increased infiltration of Vγ9Vδ2 T cells has been shown to have the highest prognostic value compared with other immune subsets. In acute myeloid leukemia (AML), similar findings have been based solely on the inference of transcriptomic data and have not been assessed with respect to confounding factors. This study aimed at determining, by immunophenotypic analysis (flow or mass cytometry) of peripheral blood from patients with AML at diagnosis, the prognostic impact of Vγ9Vδ2 T-cell frequency. This was adjusted for potential confounders (age at diagnosis, disease status, European LeukemiaNet classification, leukocytosis, and allogeneic hematopoietic stem cell transplantation as a time-dependent covariate). The cohort was composed of 198 patients with newly diagnosed (ND) AML. By univariate analysis, patients with lower Vγ9Vδ2 T cells at diagnosis had significantly lower 5-year overall and relapse-free survivals. These results were confirmed in multivariate analysis (hazard ratio [HR], 1.55 [95% confidence interval (CI), 1.04-2.30]; P = .030 and HR, 1.64 [95% CI, 1.06-2.53]; P = .025). Immunophenotypic alterations observed in patients with lower Vγ9Vδ2 T cells included a loss of some cytotoxic Vγ9Vδ2 T-cell subsets and a decreased expression of butyrophilin 3A on the surface of blasts. Samples expanded regardless of their Vγ9Vδ2 T-cell levels and displayed similar effector functions in vitro. This study confirms the prognostic value of elevated Vγ9Vδ2 T cells among lymphocytes in patients with ND AML. These results provide a strong rationale to consider consolidation protocols aiming at enhancing Vγ9Vδ2 T-cell responses.

22 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
MRMarie-Sarah Rouvière
Marie-Sarah Rouvière
NSNassim SALEM
Nassim SALEM
AAAmira Ben Amara
Amira Ben Amara
FOFlorence Orlanducci
Florence Orlanducci
DODaniel Olive
Daniel Olive
The success of immunotherapy has highlighted the critical role of the immune microenvironment in acute lymphoblastic leukemia (ALL); however, the immune landscape in ALL remains incompletely understood and most studies have focused on conventional T cells or NK cells. This study investigated the prognostic impact of circulating γδ T-cell alterations using high-dimensional analysis in a cohort of newly diagnosed adult ALL patients (10 B-ALL; 9 Philadelphia+ ALL; 9 T-ALL). Our analysis revealed common alterations in CD8+ T cells and γδ T cells of relapsed patients, including accumulation of early stage differentiation and increased expression of BTLA and CD73. We demonstrated that the circulating γδ T-cell signature was the most discriminating between relapsed and disease-free groups. In addition, Vδ2 T-cell alterations strongly discriminated patients by relapse status. Taken together, these data highlight the role of ɣδ T cells in adult ALL patients, among whom Vδ2 T cells may be a pivotal contributor to T-cell immunity in ALL. Our findings provide a strong rationale for further monitoring and potentiating Vδ2 T cells in ALL, including in the autologous setting.

3 December 2024
Verified
Other
Open access
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
CICaroline Imbert
Caroline Imbert
NBNicolas Boucherit
Nicolas Boucherit
Laurent GorvelLaurent Gorvel
Laurent Gorvel
SFStéphane Fattori
Stéphane Fattori
DODaniel Olive
Daniel Olive
Raw data from Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis

3 December 2024
Verified
Other
Open access
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
CICaroline Imbert
Caroline Imbert
NBNicolas Boucherit
Nicolas Boucherit
Laurent GorvelLaurent Gorvel
Laurent Gorvel
SFStéphane Fattori
Stéphane Fattori
DODaniel Olive
Daniel Olive
Visualization of Vγ9Vδ2 T cells (E) and SUP-T1 (T) coculture using a label-free method within 20 hours. Ratio T/E = 1/2. Cells treated with 107G3B5 antibody (10ug/ml).

3 December 2024
Verified
Other
Open access
AFAnne-Charlotte Le Floch
Anne-Charlotte Le Floch
CICaroline Imbert
Caroline Imbert
NBNicolas Boucherit
Nicolas Boucherit
Laurent GorvelLaurent Gorvel
Laurent Gorvel
SFStéphane Fattori
Stéphane Fattori
DODaniel Olive
Daniel Olive
Visualization of Vγ9Vδ2 T cells (E) and Ishikawa (T) coculture using a label-free method within 20 hours. Ratio T/E = 1/2. Cells treated with 10ug/ml of mIgG1 control antibody.